27 Apr Pectin K suspension (Kaolin 3 g Pectin 0,220 g)
| Company name & address | Product | Registration number | Batch number(s) | Expiry date | Pack size | First distributed | Re-call Classification | Recall date |
| PHARMACORP (PTY) LTD
29 Victoria Link, |
Pectin K suspension |
X/11.9/394
|
133 | 06/2027 | 100 mL | 10 July 2025 | Class II Type C | 15.September.2025 |
| Pectin K suspension | X/11.9/394 | 134 | 06/2027 | 100 mL |
08 July 2025 |
Class II Type C | 15.September.2025 |
Reason for recall
This recall is initiated because Pharmacorp (Pty) Ltd found that there is microbial contamination present on two Pectin-K batches. Testing for microbial contamination is not a mandatory test required for release, however Pharmacorp requests this test on a routine basis. When results were received, both batches were already release and sold from the Distributor, for this reason, these batches are being recalled as precautionary measure.
Advice to HCPs/Distributors/Public
Pharmacorp (Pty) Ltd request you to refrain from selling any of the affected batches of Pectin-K and return stock to the supplying warehouse or distributor with immediate effect. Your stock will be collected and credited accordingly.
Proposed action taken and its urgency: A SAHPRA approved recall letter was distributed to all distribution points, and the recall process was started.
Reporting side effects
Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.